Pediatric Diazepam Dosing
For pediatric patients 6 months and older, diazepam dosing varies by indication: for status epilepticus use 0.1-0.3 mg/kg IV every 5-10 minutes (maximum 10 mg per dose), for rectal administration use 0.5 mg/kg (maximum 20 mg), and for sedation/anxiolysis use 0.05-0.10 mg/kg IV (maximum 5 mg per dose) or 0.25-0.50 mg/kg PO (maximum 20 mg), with children under 6 years potentially requiring up to 1 mg/kg orally. 1, 2
Route-Specific Dosing
Intravenous Administration
Status Epilepticus:
- Dose: 0.1-0.3 mg/kg IV every 5-10 minutes
- Maximum single dose: 10 mg
- Administration: Give over approximately 2 minutes to avoid pain at IV site 1
- Critical caveat: Diazepam must be followed immediately by a long-acting anticonvulsant (phenytoin/fosphenytoin) because it redistributes rapidly and seizures often recur within 15-20 minutes 1
Sedation/Anxiolysis:
- Dose: 0.05-0.10 mg/kg IV over 2-3 minutes
- Maximum single dose: 5 mg
- Peak effect: 3-5 minutes
- Redosing strategy: Dose/observe/redose every 3-5 minutes to avoid oversedation 1
Rectal Administration
Status Epilepticus (when IV access unavailable):
- Dose: 0.5 mg/kg
- Maximum: 20 mg per dose
- Important limitation: Absorption may be erratic 1
- Effectiveness: Research demonstrates 81% efficacy with doses ranging 0.16-0.57 mg/kg, though recurrence before ED arrival occurred in 30.8% 3
Oral Administration
Sedation/Anxiolysis:
- Standard dose: 0.25-0.50 mg/kg PO
- Maximum: 20 mg
- Children <6 years: May require up to 1 mg/kg 1
Chronic Management (per FDA label):
- Initial dose: 1-2.5 mg, 3-4 times daily
- Titration: Increase gradually as needed and tolerated 2
Intramuscular Administration
Seizures:
- Dose: 0.2 mg/kg
- Maximum: 6 mg per dose
- Repeat interval: Every 10-15 minutes if needed 1
- Important note: IM route generally not recommended for diazepam due to tissue necrosis risk; other benzodiazepines (lorazepam, midazolam) preferred for IM use 1
Age-Specific Considerations
Infants <6 months:
- Contraindication: Safety and effectiveness not established 2
- Enzyme system: Not fully developed, especially in premature infants, leading to prolonged drug breakdown 2
Children <5 years:
- Oral sedation: 0.25 mg/kg produces less sedation compared to older children; 0.5 mg/kg eliminates this age difference 4
- Paradoxical agitation: More common in younger children, especially with IV midazolam (though this applies to benzodiazepine class) 1
Critical Safety Warnings
Respiratory Depression:
- Increased risk when given rapidly IV or combined with other sedative agents (particularly opioids) 1
- Monitoring required: Oxygen saturation and respiratory effort
- Preparation essential: Be ready to support ventilation
- Reversal agent: Flumazenil available but counteracts anticonvulsant effects and may precipitate seizures 1
Dosing Pitfalls:
- IM route carries tissue necrosis risk—avoid for diazepam specifically 1
- Rectal absorption is erratic; IV route preferred when available 1
- Short duration of action (15-20 minutes for seizure control) necessitates immediate follow-up with long-acting anticonvulsant 1
- Do NOT use in neonates whose mothers have long-term opioid use due to acute withdrawal risk 1
Comparative Context
While the evidence provided focuses on diazepam, lorazepam may be preferred for status epilepticus due to prolonged duration of anticonvulsant activity 1. However, when diazepam is used, the dosing parameters above from AAP guidelines 1 and FDA labeling 2 provide the most authoritative framework for safe administration across pediatric age groups and clinical scenarios.